• T0070907: A Practical PPARγ Antagonist Guide

  2026-08-18

  T0070907 is a high-affinity, covalent PPARγ antagonist for separating receptor-dependent transcription from downstream cellular phenotypes. This guide shows how to deploy it in adipogenesis, macrophage foam-cell, and cervical cancer workflows while controlling solvent, timing, and PPARγ-independent effects.

• Tamoxifen: Mechanism and Research Benchmarks

  2026-08-18

  Tamoxifen is a selective estrogen receptor modulator with tissue-dependent estrogen receptor activity and broad utility in breast cancer research. Its validated research roles include CreER-mediated gene knockout, cellular stress and death assays, and exploratory antiviral testing, but each application requires model-specific controls.

• Dimetridazole: From Antimicrobial to Virulence Tool

  2026-08-17

  Dimetridazole, also known as 1,2-Dimethyl-5-nitroimidazole, is gaining attention as a context-dependent research tool for quorum sensing disruption, biofilm formation suppression, and antibiotic combination studies. This thought-leadership analysis connects mechanism, assay design, and infection model research while defining the translational boundaries of current evidence.

• Lisinopril Dihydrate: A Translational ACE Benchmark

  2026-08-17

  Lisinopril dihydrate is more than a blood-pressure tool: it is a mechanistically anchored ACE inhibitor for linking renin–angiotensin signaling to disease-model outcomes. This article examines its biochemical rationale, peptidase selectivity, experimental validation, handling strategy, and translational value across hypertension, heart failure, myocardial injury, and diabetic nephropathy research.

• DNase I (RNase-free) for Reliable Cell Assays

  2026-08-16

  This scenario-driven guide explains how DNase I (RNase-free), SKU K1088, can improve DNA removal for RNA extraction, RT-PCR, in vitro transcription, and chromatin workflows that accompany cell viability, proliferation, and cytotoxicity studies. It also provides practical controls, optimization steps, and criteria for evaluating enzyme quality, cost-efficiency, and usability.

• Puromycin Dihydrochloride in mRNA Assays

  2026-08-15

  Puromycin dihydrochloride is more than a routine selection reagent: it can help separate translation competence, cell survival, and delivery performance in advanced mRNA experiments. This article connects its ribosome-level mechanism with the localized p21 mRNA–LNP strategy reported for bladder cancer research.

• Annexin V-FITC/PI Apoptosis Assay Kit Guide

  2026-08-14

  The Annexin V-FITC/PI Apoptosis Assay Kit provides a practical two-parameter method for separating viable, early apoptotic, and membrane-compromised cell populations by flow cytometry or fluorescence microscopy. It is intended for research use only; results should be validated for each cell type and should not be treated as diagnostic evidence or as proof of a specific death mechanism.

• A Multimodal iPSC Platform for Cystic Fibrosis Drug Testing

  2026-08-14

  Berical and colleagues developed a patient-derived induced pluripotent stem cell platform that generates airway epithelial models from individuals with common and rare CFTR variants. By combining three-dimensional forskolin-induced spheroid swelling with polarized mucociliary airway cultures, the study detected genotype-specific baseline function and responses to CFTR modulators, creating a practical framework for rare-variant therapeutic research.

• Y-27632 Dihydrochloride in Gut Neurobiology

  2026-08-13

  A translational framework for using Y-27632 dihydrochloride as both a cell-survival aid and a mechanistic ROCK perturbation in engineered gut neuro-epithelial models.

• AZD1390: Selective ATM Kinase Inhibitor

  2026-08-13

  AZD1390 is a potent ATM kinase inhibitor for cancer research and DNA damage response studies. Product data report cellular ATM inhibition at 0.78 nM and radiosensitization activity in glioma and lung cancer models.

• Live-Dead Cell Staining Kit for Scaffold Studies

  2026-08-12

  Use dual-fluorescence viability readouts to distinguish membrane-intact and membrane-compromised cells in drug, biomaterial, and hydrogel experiments. This workflow shows how Calcein-AM and PI staining can strengthen scaffold cytocompatibility testing while avoiding common imaging and flow-cytometry errors.

• EPZ-6438: Mechanism and EZH2 Inhibitor Evidence

  2026-08-12

  EPZ-6438 is a selective EZH2 inhibitor that suppresses PRC2-dependent H3K27me3 formation. Its nanomolar biochemical activity, cancer-cell effects, and xenograft responses make it a useful tool for epigenetic cancer research.

• Homer1a, Caspase-6, and Inflammatory Pain

  2026-08-11

  A 2025 rat study identifies a Homer1a–caspase-6–TNF-α axis in carrageenan-induced inflammatory pain. Pharmacological inhibition and Homer1a overexpression both reduced microglial activation, TNF-α signaling, and thermal hypersensitivity, positioning caspase-6 as a non-apoptotic inflammatory mediator in the spinal dorsal horn.

• Nile Red for Reliable Lipid Droplet Assays

  2026-08-11

  Learn how Nile Red (SKU B8209) can clarify intracellular lipid droplet staining, distinguish membrane and droplet signals, and complement viability or cytotoxicity workflows. This scenario-based guide covers spectral selection, solvent compatibility, interpretation, and practical vendor evaluation.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-08-10

  FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin reagent for visualizing α-D-glucose and α-D-mannose moieties on cell surfaces and tissue-associated glycoproteins or glycolipids. It is suited to immunofluorescence staining, fluorescence microscopy, and flow cytometry carbohydrate workflows, but not to non-carbohydrate targets or as a universal stain for all glycans.

8712 records 9/581 page Previous Next First page 上5页 678910 下5页 Last page